U.S. to resume J&J COVID-19 vaccinations despite rare clot risk
Published
The government uncovered 15 vaccine recipients who developed a highly unusual kind of blood clot, out of nearly 8 million people given the J&J shot
Full ArticlePublished
The government uncovered 15 vaccine recipients who developed a highly unusual kind of blood clot, out of nearly 8 million people given the J&J shot
Full ArticleSAN FRANCISCO (AP) — A San Francisco Bay Area man in his 30s is recuperating after developing a rare blood clot in his leg within..
U.S. health officials lifted an 11-day pause on COVID-19 vaccinations using Johnson & Johnson's single-dose shot on Friday, after..
U.S. health officials are weighing next steps as they investigate a handful of unusual blood clots in people who received Johnson &..